MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Sex differences in motor response to levodopa in early Parkinson’s disease

    M. Gevertzman, A. Hooyman, J. Longhurst, M. Landers (Las Vegas, USA)

    Objective: To evaluate differences between males and females in trajectory of motor response to levodopa in early Parkinson’s disease (PD). Background: Previous research has shown…
  • 2023 International Congress

    Genetic spectrum of monogenic dystonia in Asian Indian patients

    R. Rajan, A. Saini, R. Mewara, B. Verma, D. Radhakrishnan, A. Agarwal, E. A, A. Gupta, V. V Y, M. Singh, R. Bhatia, I. Singh, R. Mir, F. Mohammad, B. B K, V. Scaria, A. Srivastava, M V. Srivastava (New Delhi, India)

    Objective: We aimed to identify potentially pathogenic genomic variations associated with dystonia in Asian Indian patients using whole exome sequencing. Background: Genomic variations associated with…
  • 2023 International Congress

    PSP registry: preliminary cross-sectional results of the first 2 years of recruitment of a multicenter registry and biorepository.

    C. Painous, M. Fernandez, M. Soto, A. Cámara, Y. Compta (Barcelona, Catalonia)

    Objective: To establish a multicenter PSP registry and biorepository in a province covering an area of 5,500,000 inhabitants, with 14 local and university hospitals. Background:…
  • 2023 International Congress

    Levodopa-Entacapone-Carbidopa Intestinal Gel in advanced Parkinson’s disease: a single center experience

    V. Constantin, S. Szatmari, K. Orban-Kis, S. Bataga, R. Neagoe, M. Ciorba, I. Mihaly, K. Kelemen, J. Szasz (Targu Mures, Romania)

    Objective: To evaluate the efficacy of Levodopa-Entacapone-Carbidopa Intestinal Gel (LECIG) in achieving adequate control of motor complications in patients with advanced Parkinson’s Disease (APD). Background:…
  • 2023 International Congress

    Cervical Dystonia Patients with Psychiatric Disorders Show More Motor and Less Non-Motor Improvement after DBS surgery.

    A. Weide, A. Khanom, Y. Wiggerts, A. Macerollo, M. Beudel, R. de Bie, Y. Namavar, R. Schuurman, J. Osman-Farah (Amsterdam, Netherlands)

    Objective: To study the influence of psychiatric disorders on the outcome of deep brain stimulation (DBS) for cervical dystonia (CD). Background: DBS is an established…
  • 2023 International Congress

    PDQ-39 predicts quality of life improvement following neurostimulation for Parkinson’s disease: Prospective observational study

    L. Torrão, M. Rosas, J. Massano, A. Oliveira, C. Chamadoira, M. Rito, J. Guimarães, C. Soares (Póvoa de Varzim, Portugal)

    Objective: The primary outcome was assessing QoL of a cohort of patients with PD before and after undergoing DBS surgery, measured using PDQ-39 questionary. Secondary…
  • 2023 International Congress

    Artificial intelligence for the improvement of imaging biomarkers in Parkinson’s disease

    V. Dzialas, E. Doering, K. Simonyan, A. Strafella, D. Vaillancourt, T. van Eimeren (Cologne, Germany)

    Objective: To systematically review the current literature on the application of artificial intelligence (AI) for imaging biomarkers in Parkinson's disease (PD) and to identify translational…
  • 2023 International Congress

    Evaluation of structural brain stem measurements for the differential diagnosis of MSA and IPD

    M. Loffeld, S. Kannenberg, A. Hausmann, C. Hartmann, J. Caspers, C. Rubbert, A. Schnitzler (Düsseldorf, Germany)

    Objective: To evaluate structural brain stem measurements to differentiate multiple system atrophy (MSA) from idiopathic Parkinson‘s disease (IPD). Background: MSA is a sporadic, progressive, neurodegenerative…
  • 2023 International Congress

    Applying the COM-B model to identify potential barriers for in-person on-site visits within the Healthy Brain Ageing (HeBA) study in Luxembourg

    L. Vilas Boas, O. Tsurkalenko, T. Marques, E. Thiry, AM. Hanff, R. Krüger, C. Horlings, A. Garrido, C. Vega, S. Schade, P. Mahlknecht, C. Gomes, S. Ghosh, K. Rege, R. Rawal, C. Pauly, D. Mcintyre, K. Seppi, M. Martí, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, B. Mollenhauer (Strassen, Luxembourg)

    Objective: This study aims to (1) apply the Capability, Opportunity, and Motivation model of Behaviour (COM-B) to the HeBA online survey to identify potential barriers that could…
  • 2023 International Congress

    Subjective cognitive decline as predictor of objective cognitive decline in Parkinson’s patients

    T. Blum, H. Wurp, S. Wolfsgruber, M. Wagner, L. Consortium, R. Dodel (Essen, Germany)

    Objective: The present study cross-sectionally and longitudinally explores the predictive value of subjective cognitive decline (SCD) regarding objective cognitive decline in a large clinical sample…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley